netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
04.06  Expand sub section  Drugs used in nausea and vertigo
04.06  Expand sub section  Antihistamines
04.06  Expand sub section  Phenothiazines and related drugs
04.06  Expand sub section  Domperidone and metoclopramide
Domperidone
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Domperidone Tablet 10mg

The MHRA has advised that there is a small risk of serious ventricular arrhythmia and sudden cardiac death with domperidone. See link below

MHRA advice: Domperidone- risk of cardiac side-effects (Dec 2014)

MHRA (Dec 2019): Domperidone is no longer licensed for use in children younger than 12 or those weighing less than 35 kg. 

 
Link  MHRA Alert on Domperidone (Dec 2019)
Link  MHRA May 2014 - Domperidone: risks of cardiac side effects
   
Metoclopramide
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
Metoclopramide HCl Tablet 10mg

Avoid SR form as very expensive. Do not use in people <20 years. MHRA recommend use for no more than 5 days.

 
Link  EMEA for Metoclopramide
Link  MHRA Aug 2013 - Metoclopramide: risk of neurological adverse effects
Link  MHRA Guidance - Metroclopramide
   
04.06  Expand sub section  5HT3 antagonists to top
04.06  Expand sub section  Neurokinin receptor antagonist
04.06  Expand sub section  Other drugs for Ménière's disease
 ....
 Non Formulary Items
Domperidone  (Motilium®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Metoclopramide Hydrochloride  (Maxolon®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Metoclopramide Hydrochloride  (Maxolon® High Dose)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Metoclopramide Hydrochloride  (Maxolon® SR)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.  

Amber

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care.  

Amber E

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement)   

Green

Suitable first-line drugs for implementation in Primary Care  

On Formulary

South Staffs Formulary Choice  

netFormulary